Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial
Navarese et al., Cardiology Journal, doi:10.5603/CJ.a2022.0072
https://c19early.org/navaresevrp.html